Copy
Wanted to let you know about happenings at CPN!
View this email in your browser
What We are Up To!


National Psoriatic Arthritis Day (October 19) and World Psoriasis Day (October 29) are coming up!







Connect with us on Twitter @PsoriasisCanada  and Facebook @Cdnpsoriasisnetwork and stay tuned for member updates!



 



CPN is pleased to be joining over 100 dermatology patient leaders at the GlobalSkin 2019 Conference, hosted by International Alliance of Dermatology Patient Organizations on June 7-9, 2019 in Milan, Italy.


 
What's New in Canada
Last week the Province of British Columbia (B.C.) announced an expansion of its use of biosimilars in the province. You can find the announcement here.  

This current policy update affects people in B.C. who are enrolled in a provincial PharmaCare program drug plan for access to Enbrel for psoriatic arthritis or Remicade for psoriasis or psoriatic arthritis.

If you live with psoriasis or psoriatic arthritis in B.C. and are affected by this policy update, please let us know
Easy access to a range of treatment options is essential for people living with psoriasis and psoriatic arthritis. Here are some updates since our last email  about what's happening in Canada.
Health Canada approved TREMFYA ONE-PRESS™ (guselkumab), a patient-controlled injector for adults with moderate-to-severe plaque psoriasis.

CADTH’s Common Drug Review gave a positive recommendation for SKYRIZI™ (risankizumab) to be reimbursed with conditions for the treatment of moderate to severe plaque psoriasis in adults. Thanks to everyone who participated in the patient survey CPN submitted to to this review!

Taltz® (ixekizumab) has been added to B.C.’s PharmaCare program as a limited coverage benefit for psoriatic arthritis.

Enstilar® (calcipotriol and betamethasone dipropionate), a new topical treatment option for psoriasis, is now listed on Nova Scotia Pharmacare.
You are receiving this email because you signed up to be a member of the Canadian Psoriasis Network at www.canadianpsoriasisnetwork.com. 



N.B. The naming or omission of any product, resource, or therapy in this email does not
imply endorsement or disapproval by CPN.
Copyright © 2018 Canadian Psoriasis Network. All rights reserved.

Our mailing address is:
328 Bartlett Ave. Toronto, ON M6H 3G7

unsubscribe from this list    update subscription preferences 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Canadian Psoriasis Network · 328 Bartlett Ave · Suite 809 · Toronto, Ontario M6H 3G7 · Canada

Email Marketing Powered by Mailchimp